According to Zen Score, the 3 best medical care facility stocks to buy right now are:
1. Cross Country Healthcare (NASDAQ:CCRN)
Cross Country Healthcare (NASDAQ:CCRN) is the top medical care facility stock with a Zen Score of 61, which is 31 points higher than the medical care facility industry average of 30. It passed 19 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -23.62% over the past year, underperforming other medical care facility stocks by -27 percentage points.
Cross Country Healthcare has an average 1 year
price target of $20.80, an upside of 21.35% from Cross Country Healthcare's current stock price of $17.14.
Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Cross Country Healthcare, 20% have issued a Strong Buy rating, 20% have issued a Buy, 60% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.
2. Addus Homecare (NASDAQ:ADUS)
Addus Homecare (NASDAQ:ADUS) is the second best medical care facility stock with a Zen Score of 56, which is 26 points higher than the medical care facility industry average of 30. It passed 18 out of 33 due diligence checks and has strong fundamentals. Addus Homecare has seen its stock lose -15.99% over the past year, underperforming other medical care facility stocks by -19 percentage points.
Addus Homecare has an average 1 year
price target of $102.60, an upside of 8.53% from Addus Homecare's current stock price of $94.54.
Addus Homecare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 5 analysts covering Addus Homecare, 20% have issued a Strong Buy rating, 60% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 20% have issued a Strong Sell.
3. Chemed (NYSE:CHE)
Chemed (NYSE:CHE) is the third best medical care facility stock with a Zen Score of 54, which is 24 points higher than the medical care facility industry average of 30. It passed 20 out of 38 due diligence checks and has strong fundamentals. Chemed has seen its stock lose -0.05% over the past year, underperforming other medical care facility stocks by -3 percentage points.
Chemed has an average 1 year
price target of $681.00, an upside of 21.52% from Chemed's current stock price of $560.42.
Chemed stock has a consensus Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Chemed, 0% have issued a Strong Buy rating, 100% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.